162 related articles for article (PubMed ID: 37820283)
41. Alcohol, liver disease and the gut microbiota.
Bajaj JS
Nat Rev Gastroenterol Hepatol; 2019 Apr; 16(4):235-246. PubMed ID: 30643227
[TBL] [Abstract][Full Text] [Related]
42. Proteomic analysis of alcohol-associated hepatitis reveals glycoprotein NMB (GPNMB) as a novel hepatic and serum biomarker.
Harris PS; Michel CR; Yun Y; McGinnis CD; Assiri MA; Ahmadi AR; Sun Z; Roede JR; Burchill MA; Orlicky DJ; McCullough RL; Fritz KS
Alcohol; 2022 Mar; 99():35-48. PubMed ID: 34923085
[TBL] [Abstract][Full Text] [Related]
43. Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure.
Parés A; Deulofeu R; Cisneros L; Escorsell A; Salmerón JM; Caballería J; Mas A
Crit Care; 2009; 13(1):R8. PubMed ID: 19175915
[TBL] [Abstract][Full Text] [Related]
44. Increased hepatocellular protein carbonylation in human end-stage alcoholic cirrhosis.
Shearn CT; Orlicky DJ; Saba LM; Shearn AH; Petersen DR
Free Radic Biol Med; 2015 Dec; 89():1144-53. PubMed ID: 26518673
[TBL] [Abstract][Full Text] [Related]
45. Integrative analysis of the gut microbiota and faecal and serum short-chain fatty acids and tryptophan metabolites in patients with cirrhosis and hepatic encephalopathy.
Wang Q; Chen C; Zuo S; Cao K; Li H
J Transl Med; 2023 Jun; 21(1):395. PubMed ID: 37330571
[TBL] [Abstract][Full Text] [Related]
46. The role of the microbiome in liver disease.
Schöler D; Schnabl B
Curr Opin Gastroenterol; 2024 May; 40(3):134-142. PubMed ID: 38362864
[TBL] [Abstract][Full Text] [Related]
47. Probiotics-Based Treatment as an Integral Approach for Alcohol Use Disorder in Alcoholic Liver Disease.
Fuenzalida C; Dufeu MS; Poniachik J; Roblero JP; Valenzuela-Pérez L; Beltrán CJ
Front Pharmacol; 2021; 12():729950. PubMed ID: 34630107
[TBL] [Abstract][Full Text] [Related]
48. Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases.
Park JW; Kim SE; Lee NY; Kim JH; Jung JH; Jang MK; Park SH; Lee MS; Kim DJ; Kim HS; Suk KT
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008852
[TBL] [Abstract][Full Text] [Related]
49. Gut dysbiosis as a driver in alcohol-induced liver injury.
Fairfield B; Schnabl B
JHEP Rep; 2021 Apr; 3(2):100220. PubMed ID: 33598648
[TBL] [Abstract][Full Text] [Related]
50.
Zhong X; Cui P; Jiang J; Ning C; Liang B; Zhou J; Tian L; Zhang Y; Lei T; Zuo T; Ye L; Huang J; Chen H
Front Cell Infect Microbiol; 2021; 11():649060. PubMed ID: 33816353
[TBL] [Abstract][Full Text] [Related]
51. Gut-liver axis and sterile signals in the development of alcoholic liver disease.
Szabo G; Petrasek J
Alcohol Alcohol; 2017 Jul; 52(4):414-424. PubMed ID: 28482064
[TBL] [Abstract][Full Text] [Related]
52. Plasma microbiome-modulated indole- and phenyl-derived metabolites associate with advanced atherosclerosis and postoperative outcomes.
Cason CA; Dolan KT; Sharma G; Tao M; Kulkarni R; Helenowski IB; Doane BM; Avram MJ; McDermott MM; Chang EB; Ozaki CK; Ho KJ
J Vasc Surg; 2018 Nov; 68(5):1552-1562.e7. PubMed ID: 29248242
[TBL] [Abstract][Full Text] [Related]
53. Fibrogenesis in alcoholic liver disease.
Fujii H; Kawada N
World J Gastroenterol; 2014 Jul; 20(25):8048-54. PubMed ID: 25009376
[TBL] [Abstract][Full Text] [Related]
54. Non-invasive Qualitative Urinary Metabolomic Profiling Discriminates Gut Microbiota Derived Metabolites in the Moderate and Chronic Alcoholic Cohorts.
Dabur R; Shirolkar A; Mishra V; Yadav BS
Curr Pharm Biotechnol; 2017; 18(14):1175-1189. PubMed ID: 29521221
[TBL] [Abstract][Full Text] [Related]
55. Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids.
Way GW; Jackson KG; Muscu SR; Zhou H
Cells; 2022 Apr; 11(8):. PubMed ID: 35456053
[TBL] [Abstract][Full Text] [Related]
56. New strain of
Jiang XW; Li YT; Ye JZ; Lv LX; Yang LY; Bian XY; Wu WR; Wu JJ; Shi D; Wang Q; Fang DQ; Wang KC; Wang QQ; Lu YM; Xie JJ; Li LJ
World J Gastroenterol; 2020 Oct; 26(40):6224-6240. PubMed ID: 33177795
[TBL] [Abstract][Full Text] [Related]
57. Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in mice.
Zhang X; Wang H; Yin P; Fan H; Sun L; Liu Y
Lipids Health Dis; 2017 Feb; 16(1):44. PubMed ID: 28228158
[TBL] [Abstract][Full Text] [Related]
58. In-depth investigation of the mechanisms of Echinacea purpurea polysaccharide mitigating alcoholic liver injury in mice via gut microbiota informatics and liver metabolomics.
Jiang W; Zhu H; Liu C; Hu B; Guo Y; Cheng Y; Qian H
Int J Biol Macromol; 2022 Jun; 209(Pt A):1327-1338. PubMed ID: 35461865
[TBL] [Abstract][Full Text] [Related]
59. Inulin Ameliorates Alcoholic Liver Disease via Suppressing LPS-TLR4-Mψ Axis and Modulating Gut Microbiota in Mice.
Yang X; He F; Zhang Y; Xue J; Li K; Zhang X; Zhu L; Wang Z; Wang H; Yang S
Alcohol Clin Exp Res; 2019 Mar; 43(3):411-424. PubMed ID: 30589437
[TBL] [Abstract][Full Text] [Related]
60. Alcohol and the liver.
Glouberman S
Ariz Med; 1979 Mar; 36(3):186-8. PubMed ID: 435107
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
